SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-24-000042
Filing Date
2024-08-13
Accepted
2024-08-13 16:33:13
Documents
20
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K angn-20240813.htm   iXBRL 8-K 23910
2 EX-99.1 secondquarter2024financi.htm EX-99.1 19291
6 secondquarter2024financi001.jpg GRAPHIC 258265
7 secondquarter2024financi002.jpg GRAPHIC 205372
8 secondquarter2024financi003.jpg GRAPHIC 143411
9 secondquarter2024financi004.jpg GRAPHIC 194038
10 secondquarter2024financi005.jpg GRAPHIC 334718
11 secondquarter2024financi006.jpg GRAPHIC 143577
  Complete submission text file 0001601485-24-000042.txt   1943282

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20240813.xsd EX-101.SCH 1989
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20240813_lab.xml EX-101.LAB 22786
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20240813_pre.xml EX-101.PRE 13130
22 EXTRACTED XBRL INSTANCE DOCUMENT angn-20240813_htm.xml XML 2816
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 241202234
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)